{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:30:04Z","timestamp":1794576604463,"version":"4.9.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Here, we investigate the impact of phage-antibiotic combinations (PAC) on bacterial killing, resistance development and outer membrane vesicle (OMV) production in multidrug-resistant (MDR) P. aeruginosa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and Results<\/jats:title>\n                  <jats:p>After screening 10 well-characterized MDR P. aeruginosa strains against three P. aeruginosa phages, representative strains, R10266 and R9316, were selected for synergy testing based on high phage sensitivity and substantial antibiotic resistance patterns, while phage EM was chosen based on host range. To understand the impact of phage-antibiotic combinations (PAC) against MDR P. aeruginosa, time-kill analyses, OMV quantification and phage\/antibiotic resistance testing were performed. Phage and meropenem demonstrated synergistic activity against both MDR strains. Triple combination regimens, phage-meropenem-colistin and phage-ciprofloxacin-colistin, resulted in the greatest CFU reduction for strains R9316 (3.50 log10 CFU ml\u22121) and R10266 (4.50 log10 CFU ml\u22121) respectively. PAC resulted in regained and improved antibiotic susceptibility to ciprofloxacin (MIC 2 to 0.0625) and meropenem (MIC 32 to 16), respectively, in R9316. Phage resistance was prevented or reduced in the presence of several classes of antibiotics and OMV production was reduced in the presence of phage for both strains, which was associated with significantly improved bacterial eradication.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings support the potential of phage-antibiotic synergy (PAS) to augment killing of MDR P. aeruginosa. Systematic in vitro and in vivo studies are needed to better understand phage interactions with antipseudomonal antibiotics, to define the role of OMV production in P. aeruginosa PAC therapy and to outline pharmacokinetic and pharmacodynamic parameters conducive to PAS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Significance and Impact of Study<\/jats:title>\n                  <jats:p>This study identifies novel bactericidal phage-antibiotic combinations capable of thwarting resistance development in MDR and XDR P. aeruginosa strains. Furthermore, phage-mediated OMV reduction is identified as a potential mechanism through which PAC potentiates bacterial killing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jam.15647","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T13:13:12Z","timestamp":1654175592000},"page":"1636-1649","source":"Crossref","is-referenced-by-count":51,"title":["Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: <i>In vitro<\/i> synergy testing"],"prefix":"10.1093","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7171-7015","authenticated-orcid":false,"given":"Dana J.","family":"Holger","sequence":"first","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Lev","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Kebriaei","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Morrisette","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"},{"name":"Department of Clinical Pharmacy & Outcomes Sciences, Medical University of South Carolina College of Pharmacy Charleston South Carolina USA"},{"name":"Department of Pharmacy, Services Medical University of South Carolina Shawn Jenkins Children's Hospital Charleston South Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahi","family":"Shah","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Virology and Immunology AdventHealth Central Florida Orlando Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Lehman","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-0081","authenticated-orcid":false,"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA"},{"name":"Department of Pharmacy Services, Detroit Receiving Hospital Detroit Medical Center Detroit Michigan USA"},{"name":"Department of Medicine, Division of Infectious Diseases Wayne State University Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2023011711345847800_jam15647-bib-0001","volume-title":"Doi:performance standards for antimicrobial susceptibility testing; 30th informational supplement","author":"\u2018Clinical and Laboratory Standards Institute\u2019","year":"2020"},{"issue":"9","key":"2023011711345847800_jam15647-bib-0002","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from first ten consecutive cases of intravenous bacteriophage therapy to treat multidrug resistant bacterial infections at a single center in the US","volume":"7","author":"Aslam","year":"2022","journal-title":"Open Forum Infectious Diseases [Preprint]"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0003","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MCP.0b013e32835f27be","article-title":"Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management","volume":"19","author":"Barbier","year":"2013","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"9\u201310","key":"2023011711345847800_jam15647-bib-0004","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.micinf.2006.05.001","article-title":"Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response","volume":"8","author":"Bauman","year":"2006","journal-title":"Microbes and infection \/ Institut Pasteur"},{"issue":"Pt 2","key":"2023011711345847800_jam15647-bib-0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.0022-2720.2004.01348.x","article-title":"FM-dyes as experimental probes for dissecting vesicle trafficking in living plant cells","volume":"214","author":"Bolte","year":"2004","journal-title":"Journal of Microscopy"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends in Microbiology"},{"issue":"21","key":"2023011711345847800_jam15647-bib-0007","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1919888117","article-title":"Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance","volume":"117","author":"Burmeister","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2023011711345847800_jam15647-bib-0008","doi-asserted-by":"crossref","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the United States, 2019","author":"Centers for Disease Control and Prevention U.S.","year":"2019"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0009","doi-asserted-by":"crossref","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Scientific Reports"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/45.1.9","article-title":"Chromosomal \u03b2-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa","volume":"45","author":"Ciofu","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"2023011711345847800_jam15647-bib-0012","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/v6103778","article-title":"Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms","volume":"6","author":"Coulter","year":"2014","journal-title":"Viruses"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0013","article-title":"Synergistic killing and re-sensitization of Pseudomonas aeruginosa to antibiotics by phage-antibiotic combination treatment","volume":"14","author":"Engeman","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0014","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/AAC.00242-10","article-title":"Adaptive resistance to the \u201clast Hope\u201d antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS","volume":"54","author":"Fern\u00e1ndez","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"2023011711345847800_jam15647-bib-0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1534734619835115","article-title":"Bacteriophage therapy of chronic nonhealing wound: clinical study","volume":"18","author":"Gupta","year":"2019","journal-title":"The International Journal of Lower Extremity Wounds"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/mdr.2006.12.164","article-title":"Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage","volume":"12","author":"Hagens","year":"2006","journal-title":"Microbial Drug Resistance"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/ph12010035","article-title":"Phages for phage therapy: isolation, Characterization, and Host Range Breadth","volume":"12","author":"Hyman","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"12","key":"2023011711345847800_jam15647-bib-0018","first-page":"1803","article-title":"Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"14","key":"2023011711345847800_jam15647-bib-0019","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/jb.177.14.3998-4008.1995","article-title":"Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion","volume":"177","author":"Kadurugamuwa","year":"1995","journal-title":"Journal of Bacteriology"},{"issue":"5","key":"2023011711345847800_jam15647-bib-0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/40.5.615","article-title":"Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release","volume":"40","author":"Kadurugamuwa","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0021","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex phage-antibiotic synergy (PAS): antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Applied and Environmental Microbiology"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0022","doi-asserted-by":"crossref","first-page":"e00315","DOI":"10.1128\/AAC.00315-18","article-title":"Influence of inoculum effect on the efficacy of daptomycin monotherapy and in combination with \u03b2-lactams against daptomycin-susceptible enterococcus faecium harboring LiaSR substitutions","volume":"62","author":"Kebriaei","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"2023011711345847800_jam15647-bib-0023","doi-asserted-by":"crossref","first-page":"e01743","DOI":"10.1128\/AAC.01743-18","article-title":"Dalbavancin alone and in combination with Ceftaroline against four different phenotypes of Staphylococcus aureus in a simulated pharmacodynamic\/pharmacokinetic model","volume":"63","author":"Kebriaei","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Pt 11","key":"2023011711345847800_jam15647-bib-0024","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/jmm.0.029744-0","article-title":"Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection","volume":"60","author":"Khawaldeh","year":"2011","journal-title":"Journal of Medical Microbiology"},{"issue":"22","key":"2023011711345847800_jam15647-bib-0025","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1299905","article-title":"Bacterial outer membrane vesicles and the host\u2013pathogen interaction","volume":"19","author":"Kuehn","year":"2005","journal-title":"Genes & Development"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant Staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"key":"2023011711345847800_jam15647-bib-0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.642541","article-title":"Could azithromycin be part of Pseudomonas aeruginosa acute pneumonia treatment?","volume":"12","author":"Leroy","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"2023011711345847800_jam15647-bib-0028","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nature Reviews Microbiology"},{"issue":"9","key":"2023011711345847800_jam15647-bib-0029","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cmi.2020.04.039","article-title":"Pharmacokinetics\/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study","volume":"26","author":"Lin","year":"2020","journal-title":"Clinical Microbiology and Infection"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clinical Microbiology and Infection"},{"key":"2023011711345847800_jam15647-bib-0031","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-11-258","article-title":"Contribution of bacterial outer membrane vesicles to innate bacterial defense","volume":"11","author":"Manning","year":"2011","journal-title":"BMC Microbiology"},{"issue":"7","key":"2023011711345847800_jam15647-bib-0032","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","article-title":"A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds","volume":"41","author":"Markoishvili","year":"2002","journal-title":"International Journal of Dermatology"},{"key":"2023011711345847800_jam15647-bib-0033","first-page":"81","volume-title":"Bacteriophages: methods and protocols, volume 1: isolation, characterization, and interactions","author":"Mazzocco","year":"2009"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0034","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00779-19","article-title":"Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or Fosfomycin against well-characterized multidrug-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"63","author":"Mikhail","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"2023011711345847800_jam15647-bib-0035","doi-asserted-by":"crossref","first-page":"e00993","DOI":"10.1128\/AAC.00993-20","article-title":"Bacteriophage-antibiotic combinations for enterococcus faecium with varying bacteriophage and daptomycin susceptibilities","volume":"64","author":"Morrisette","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0036","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.01252-10","article-title":"A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and \u03b2-lactams in Pseudomonas aeruginosa","volume":"55","author":"Muller","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"2023011711345847800_jam15647-bib-0037","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","article-title":"High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation","volume":"46","author":"Nakajima","year":"2002","journal-title":"Microbiology and Immunology"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0038","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"in vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"2023011711345847800_jam15647-bib-0039","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"issue":"6","key":"2023011711345847800_jam15647-bib-0040","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/AEM.70.6.3417-3424.2004","article-title":"Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7","volume":"70","author":"O'Flynn","year":"2004","journal-title":"Applied and Environmental Microbiology"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0041","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnology Advances"},{"key":"2023011711345847800_jam15647-bib-0042","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"2023011711345847800_jam15647-bib-0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194556","article-title":"Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation","volume":"13","author":"Sato","year":"2018","journal-title":"PLoS One"},{"key":"2023011711345847800_jam15647-bib-0044","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"8","key":"2023011711345847800_jam15647-bib-0045","doi-asserted-by":"crossref","first-page":"fiy107","DOI":"10.1093\/femsec\/fiy107","article-title":"Transient negative effects of antibiotics on phages do not jeopardise the advantages of combination therapies","volume":"94","author":"Torres-Barcel\u00f3","year":"2018","journal-title":"FEMS Microbiology Ecology"},{"issue":"4","key":"2023011711345847800_jam15647-bib-0046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary rationale for phages as complements of antibiotics","volume":"24","author":"Torres-Barcel\u00f3","year":"2016","journal-title":"Trends in Microbiology"},{"issue":"7","key":"2023011711345847800_jam15647-bib-0047","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00705-018-3811-0","article-title":"Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa","volume":"163","author":"Uchiyama","year":"2018","journal-title":"Archives of Virology"},{"issue":"2","key":"2023011711345847800_jam15647-bib-0048","first-page":"309","article-title":"Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa","volume":"17","author":"Wang","year":"2006","journal-title":"International Journal of Molecular Medicine"},{"key":"2023011711345847800_jam15647-bib-0049","doi-asserted-by":"crossref","DOI":"10.1101\/2021.07.23.453473","volume-title":"Phage resistance mechanisms increase colistin sensitivity in Acinetobacter baumannii","author":"Wang","year":"2021"},{"key":"2023011711345847800_jam15647-bib-0050","article-title":"Bacteriophage procurement for therapeutic purposes","volume":"7","author":"Weber-D\u0105browska","year":"2016","journal-title":"Frontiers in Microbiology"},{"issue":"3\u20134","key":"2023011711345847800_jam15647-bib-0051","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1529-1049(01)00015-0","article-title":"Bacteriophage therapy for infections in cancer patients","volume":"1","author":"Weber-Dabrowska","year":"2001","journal-title":"Clinical and Applied Immunology Reviews"},{"issue":"4","key":"2023011711345847800_jam15647-bib-0052","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0041-1345(03)00525-6","article-title":"Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man","volume":"35","author":"Weber-D\u0105browska","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"2023011711345847800_jam15647-bib-0053","first-page":"3","volume-title":"Bacteriophages: methods and protocols, volume 1: isolation, characterization, and interactions","author":"Wommack","year":"2009"},{"issue":"4","key":"2023011711345847800_jam15647-bib-0054","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clinical Otolaryngology"},{"issue":"1","key":"2023011711345847800_jam15647-bib-0055","first-page":"82","article-title":"Evaluation of dalbavancin alone and in combination with \u03b2-lactam antibiotics against resistant phenotypes of Staphylococcus aureus","volume":"74","author":"Xhemali","year":"2019","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"2023011711345847800_jam15647-bib-0056","article-title":"Mechanisms for rapid evolution of carbapenem resistance in a clinical isolate of Pseudomonas aeruginosa","volume":"11","author":"Xu","year":"2020","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"2023011711345847800_jam15647-bib-0057","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage therapy in implant-related infections: an experimental study","volume":"95","author":"Yilmaz","year":"2013","journal-title":"JBJS"}],"container-title":["Journal of Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jam.15647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jam.15647","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/133\/3\/1636\/48736295\/jambio1636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/133\/3\/1636\/48736295\/jambio1636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:08:24Z","timestamp":1673971704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jambio\/article\/133\/3\/1636\/6989242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jam.15647","relation":{},"ISSN":["1365-2672","1364-5072"],"issn-type":[{"value":"1365-2672","type":"electronic"},{"value":"1364-5072","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,9,1]]}}}